Literature DB >> 31687099

Inorganic Nitrate Supplementation for Cardiovascular Health.

John L Ivy1.   

Abstract

Nitric oxide (NO) is continually produced by the enzyme nitric oxide synthase (NOS) and is essential to the control and effectiveness of the cardiovascular system. However, there is a substantial reduction in NOS activity with aging that can lead to the development of hypertension and other cardiovascular complications. Fortunately, NO can also be produced by the sequential reduction of inorganic nitrate to nitrite and then to NO. Nitric oxide from inorganic nitrate supplementation has been found to have the same cardioprotective benefits of NO produced by NOS. Moreover, it can effectively compensate for declining NOS activity due to aging or NOS inhibition by oxidative stress, hypoxia, or other factors. This review covers some of the major cardiovascular regulatory actions of NO and presents evidence that NO from inorganic nitrate supplementation can provide (1) compensation when NOS activity is inadequate, and (2) cardioprotective benefits beyond that provided by a healthy NOS system. In addition, it discusses how to obtain a safe and efficacious range of inorganic nitrate.
© 2019 Houston Methodist Hospital Houston, Texas.

Entities:  

Keywords:  cardiovascular disease; leukocytes; nitrate; nitric oxide; nitric oxide synthase; nitrite; platelets

Mesh:

Substances:

Year:  2019        PMID: 31687099      PMCID: PMC6822652          DOI: 10.14797/mdcj-15-3-200

Source DB:  PubMed          Journal:  Methodist Debakey Cardiovasc J        ISSN: 1947-6108


  40 in total

Review 1.  The nitrate-nitrite-nitric oxide pathway in physiology and therapeutics.

Authors:  Jon O Lundberg; Eddie Weitzberg; Mark T Gladwin
Journal:  Nat Rev Drug Discov       Date:  2008-02       Impact factor: 84.694

2.  Acute Dietary Nitrate Intake Improves Muscle Contractile Function in Patients With Heart Failure: A Double-Blind, Placebo-Controlled, Randomized Trial.

Authors:  Andrew R Coggan; Joshua L Leibowitz; Catherine Anderson Spearie; Ana Kadkhodayan; Deepak P Thomas; Sujata Ramamurthy; Kiran Mahmood; Soo Park; Suzanne Waller; Marsha Farmer; Linda R Peterson
Journal:  Circ Heart Fail       Date:  2015-07-15       Impact factor: 8.790

Review 3.  Inorganic nitrite therapy: historical perspective and future directions.

Authors:  Christopher G Kevil; Gopi K Kolluru; Christopher B Pattillo; Tony Giordano
Journal:  Free Radic Biol Med       Date:  2011-05-04       Impact factor: 7.376

4.  Dietary nitrate supplementation enhances exercise performance in peripheral arterial disease.

Authors:  Aarti A Kenjale; Katherine L Ham; Thomas Stabler; Jennifer L Robbins; Johanna L Johnson; Mitch Vanbruggen; Grayson Privette; Eunji Yim; William E Kraus; Jason D Allen
Journal:  J Appl Physiol (1985)       Date:  2011-03-31

5.  Acute and chronic effects of dietary nitrate supplementation on blood pressure and the physiological responses to moderate-intensity and incremental exercise.

Authors:  Anni Vanhatalo; Stephen J Bailey; Jamie R Blackwell; Fred J DiMenna; Toby G Pavey; Daryl P Wilkerson; Nigel Benjamin; Paul G Winyard; Andrew M Jones
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2010-08-11       Impact factor: 3.619

6.  Nitrite-generated NO circumvents dysregulated arginine/NOS signaling to protect against intimal hyperplasia in Sprague-Dawley rats.

Authors:  Matthew J Alef; Raghuveer Vallabhaneni; Evie Carchman; Sidney M Morris; Sruti Shiva; Yinna Wang; Eric E Kelley; Margaret M Tarpey; Mark T Gladwin; Edith Tzeng; Brian S Zuckerbraun
Journal:  J Clin Invest       Date:  2011-03-23       Impact factor: 14.808

7.  Nitric oxide-generating vasodilators and 8-bromo-cyclic guanosine monophosphate inhibit mitogenesis and proliferation of cultured rat vascular smooth muscle cells.

Authors:  U C Garg; A Hassid
Journal:  J Clin Invest       Date:  1989-05       Impact factor: 14.808

8.  Enhanced vasodilator activity of nitrite in hypertension: critical role for erythrocytic xanthine oxidoreductase and translational potential.

Authors:  Suborno M Ghosh; Vikas Kapil; Isabel Fuentes-Calvo; Kristen J Bubb; Vanessa Pearl; Alexandra B Milsom; Rayomand Khambata; Sheiva Maleki-Toyserkani; Mubeen Yousuf; Nigel Benjamin; Andrew J Webb; Mark J Caulfield; Adrian J Hobbs; Amrita Ahluwalia
Journal:  Hypertension       Date:  2013-04-15       Impact factor: 10.190

9.  Nitric oxide reversibly inhibits the migration of cultured vascular smooth muscle cells.

Authors:  R Sarkar; E G Meinberg; J C Stanley; D Gordon; R C Webb
Journal:  Circ Res       Date:  1996-02       Impact factor: 17.367

10.  Role of inorganic nitrate and nitrite in driving nitric oxide-cGMP-mediated inhibition of platelet aggregation in vitro and in vivo.

Authors:  G L Apostoli; A Solomon; M J Smallwood; P G Winyard; M Emerson
Journal:  J Thromb Haemost       Date:  2014-10-01       Impact factor: 5.824

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.